ArticleOpen forum infectious diseases2024

The Designed Ankyrin Repeat Protein Antiviral Ensovibep for Nonhospitalized Patients With Coronavirus Disease 2019: Results From EMPATHY, a Randomized, Placebo-Controlled Phase 2 Study.

Jeff Kingsley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.